Skip to content

Analysis of the effectiveness and safety of adipose tissue extract in the treatment of hypertrophic scars

Analysis of the effectiveness and safety of adipose tissue extract in the treatment of hypertrophic scars

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039460
Enrollment
Unknown
Registered
2020-10-28
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertropic scar

Interventions

treatment group:Adipose tissue extract

Sponsors

Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with stable hypertrophic scars; 2. Those who willingly accept treatment and cooperate with long-term follow-up; 3. Those who are 15 to 60 years old, have no gender limitation, and the course of disease is more than 1 year.

Exclusion criteria

Exclusion criteria: 1. Keloids or unstable scars (ulceration, infection, etc.); 2. Severe vital organ diseases and patients with hematopoietic or immune system diseases who cannot tolerate surgery; 3. Those who have received physical therapy such as laser, grinding, or chemotherapy, such as tretinoin and hormone injection; 4. Patients with allergies or scars in their families; 5. Patients who are pregnant, breastfeeding, menstrual, or pregnancy preparation; 6. Patients whose family members do not agree with the operation.

Design outcomes

Primary

MeasureTime frame
Vancouver Scar Assessment Scale;

Countries

China

Contacts

Public ContactDeng Chengliang

Affiliated Hospital of Zunyi Medical University

cheliadeng@sina.com+86 15085115296

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026